Loading...
The adaptive stroma joining the antiangiogenic resistance front
Resistance to antiangiogenic therapies in cancer involves both tumor cells and stromal components, but their relative contributions differ in each cancer subtype. In this issue of the JCI, Cascone et al. describe a stromal adaptation to antiangiogenic therapy in non–small cell lung carcinoma (NSCLC)...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Clinical Investigation
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069791/ https://ncbi.nlm.nih.gov/pubmed/21436579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46430 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|